Rare diseases
Investigational molecules
Locations
331 conditions with trials, the busiest first
872 trials across Europe, recruiting first
Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Not Used Anti-TNF Therapy
CzechiaStudy of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis
AustriaSafety Study of Efgartigimod in Adults with Primary Sjögren's Syndrome
BelgiumStudy on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Systemic Lupus Erythematosus
HungaryStudy of GLPG3667 for Adults with Active Systemic Lupus Erythematosus
BulgariaStudy on Deucravacitinib and Apremilast for Patients with Active Psoriatic Arthritis New to Biologic Treatments or Previously on TNFα Inhibitors
BelgiumStudy on the Effects of Tigulixostat and Allopurinol in Patients with Gout and High Uric Acid Levels
BelgiumStudy on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments
BulgariaStudy on the Effects of VER-01, Ibuprofen, and Paracetamol for Patients with Chronic Non-Specific Low Back Pain
CzechiaStudy on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms
AustriaStudy Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment
BelgiumStudy on Long-Term Safety and Efficacy of Tildrakizumab for Adults with Psoriatic Arthritis
CzechiaThe therapies tested most often in Musculoskeletal and connective tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
